Spinnaker Investment Group, LLC Bristol Myers Squibb CO Transaction History

Spinnaker Investment Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$57.89 - $64.73 $12,214 - $13,658	211 Added 4.44%	4,966 $288,000
Q2 2023 Jul 20, 2023	BUY	$63.71 - $70.74 $2,866 - $3,183	45 Added 0.96%	4,755 $304,000
Q1 2023 Apr 13, 2023	BUY	$65.71 - $74.53 $12,024 - $13,638	183 Added 4.04%	4,710 $326,000
Q4 2022 Jan 17, 2023	BUY	$68.48 - $81.09 $10,272 - $12,163	150 Added 3.43%	4,527 $0
Q3 2022 Oct 21, 2022	BUY	$0.13 - $76.84 $58 - $34,578	450 Added 11.46%	4,377 $311,000
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $43,862 - $48,307	-604 Reduced 13.33%	3,927 $302,000
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $34,121 - $40,914	555 Added 13.96%	4,531 $332,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $213,232 - $248,579	3,976 New	3,976 $258,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Spinnaker Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Spinnaker Investment Group, LLC with notifications on news.